- Home
- CRGO vs LUNG Comparison
CRGO vs LUNG Comparison
Compare CRGO & LUNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRGO
- LUNG
- Stock Information
- Founded
- CRGO 2012
- LUNG 1995
- Country
- CRGO Spain
- LUNG United States
- Employees
- CRGO N/A
- LUNG N/A
- Industry
- CRGO Blank Checks
- LUNG Industrial Specialties
- Sector
- CRGO Finance
- LUNG Health Care
- Exchange
- CRGO Nasdaq
- LUNG Nasdaq
- Market Cap
- CRGO 118.1M
- LUNG 124.0M
- IPO Year
- CRGO N/A
- LUNG 2020
- Fundamental
- Price
- CRGO $2.45
- LUNG $2.63
- Analyst Decision
- CRGO Buy
- LUNG Buy
- Analyst Count
- CRGO 1
- LUNG 6
- Target Price
- CRGO $3.50
- LUNG $11.53
- AVG Volume (30 Days)
- CRGO 62.4K
- LUNG 359.5K
- Earning Date
- CRGO 08-18-2025
- LUNG 07-30-2025
- Dividend Yield
- CRGO N/A
- LUNG N/A
- EPS Growth
- CRGO N/A
- LUNG N/A
- EPS
- CRGO N/A
- LUNG N/A
- Revenue
- CRGO $25,375,000.00
- LUNG $87,473,000.00
- Revenue This Year
- CRGO $26.97
- LUNG $18.02
- Revenue Next Year
- CRGO $26.11
- LUNG $18.17
- P/E Ratio
- CRGO N/A
- LUNG N/A
- Revenue Growth
- CRGO 21.92
- LUNG 19.84
- 52 Week Low
- CRGO $1.27
- LUNG $2.51
- 52 Week High
- CRGO $4.42
- LUNG $9.37
- Technical
- Relative Strength Index (RSI)
- CRGO 57.94
- LUNG 33.86
- Support Level
- CRGO $2.10
- LUNG $2.51
- Resistance Level
- CRGO $2.32
- LUNG $2.80
- Average True Range (ATR)
- CRGO 0.14
- LUNG 0.21
- MACD
- CRGO 0.00
- LUNG 0.00
- Stochastic Oscillator
- CRGO 85.37
- LUNG 11.43
About CRGO Freightos Limited Ordinary shares
Freightos Ltd operates as a vendor-neutral booking and payment platform for international freight. Its platform supports supply chain efficiency and agility by enabling real-time procurement of ocean and air shipping across more than ten thousand importers/exporters. forwarders, and dozens of airlines and ocean carriers. WebCargo by Freightos is a freight platform connecting carriers and forwarders in particular an air cargo eBooking platform. Freightos.com is a digital international freight marketplace for importers and exporters for instant pricing, booking, and shipment management. The company operates in two segments-Platform segment and Solutions segment. Geographically, the company operates in Europe, Hong Kong, United States which is majority revenue generator and others.
About LUNG Pulmonx Corporation
Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.